摘要
目的观察培哚普利对糖尿病肾病(DN)肾功能及肾脏内皮素(ET)代谢的影响,探讨培哚普利防治DN的机制。方法44例无高血压、持续有微量白蛋白尿的2型糖尿病患者被随机分为培哚普利治疗组和常规治疗组。结果培噪普利治疗8周后DN患者增高的尿白蛋白(A1b)、转铁蛋白(TF)、ET排泄分别减少43.5%、48.1%、36.3%(P<0.01),而常规治疗无明显变化,相关分析示尿A1b降低和尿ET降低呈正相关(γ=0.703,P<0.01)。结论培吸普利对DN肾脏保护作用和其对肾脏局部ET合成的抑制密切相关。
Objective The mechanism of perindopril on diabetic nephropathy was investigated by observing the effects of perindopril on renal function and endothelin (ET) metbolism in diabetic patients with microalbuminuria.Methods Forty-four cases of type 2 diabetes mellitus with microalbuminuria and normotension were randomly divided into two groups: routine group and perindopril group. Results The study lasted 8 weeks, results showed that the elevated urinary albumin (A1b), transferrin (TF) and ET excretion were markedly decreased by 43. 5%, 48. 1% and 36. 3% respectively in perindopril group (P<0. 01). These parameters had no significant chang throughout the study in routine group. The reduction in urinary ET excretion was strictly related to the decrease in UAE(r = 0. 703, P<0. 01). Couclusion This study suggested that perindopril might preserve renal function in diabetic nephropathy by inhibiting renal ET production.
出处
《中国糖尿病杂志》
CAS
CSCD
1999年第6期334-336,共3页
Chinese Journal of Diabetes